Relative bioavailability of coenzyme Q10 formulation for paediatric individualized therapy

No abstract is available for this paper.

• Publication year

  2017

• Venue

  The Journal of pharmacy and pharmacology

• Publication date

  2017-05-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/jphp.12613PMID 27464712
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Coenzyme Q10

  2019cited by this paper
• New analytical strategies applied to the determination of Coenzyme Q10 in biological matrix.

  2015cited by this paper
• A simple microHPLC-UV method for the simultaneous determination of retinol and α-tocopherol in human plasma. Application to intrahepatic cholestasis of pregnancy

  2014cited by this paper
• Coenzyme Q10 stability in pediatric liquid oral dosage formulations.

  2012cited by this paper
• Lipid peroxidation, DNA damage and coenzyme Q10 in lung cancer patients--markers for risk assessment?

  2011cited by this paper
• Importance of in -vitro in -vivo studies in pharmaceutical formulation development

  2011cited by this paper
• EXTEMPORANEOUS DOSAGE FORM FOR ORAL LIQUIDS

  2011cited by this paper
• Clinical aspects of coenzyme Q10: an update.

  2010cited by this paper
• Coenzyme Q10 in neuromuscular and neurodegenerative disorders.

  2010cited by this paper
• Enhancement of solubility and dissolution of coenzyme Q10 using solid dispersion formulation.

  2010cited by this paper
• Self-microemulsifying formulation-based oral solution of coenzyme Q10.

  2009cited by this paper
• Simple, Highly Sensitive Micro HPLC Method for the Determination of Coenzyme Q10 and its Major Related Substances

  2009cited by this paper
• Effect of oxyethylene numbers on the pharmacokinetics of menatetrenone incorporated in oil-in-water lipid emulsions prepared with polyoxyethylene-polyoxypropylene block copolymers and soybean oil in rats.

  2008cited by this paper
• Coenzyme Q10 and vitamin E deficiency in Friedreich’s ataxia: predictor of efficacy of vitamin E and coenzyme Q10 therapy

  2008cited by this paper
• Coenzyme Q10: is there a clinical role and a case for measurement?

  2008cited by this paper
• Physicochemical and pharmacokinetic characterization of water-soluble Coenzyme Q(10) formulations.

  2008cited by this paper
• Early coenzyme Q10 supplementation in primary coenzyme Q10 deficiency.

  2008cited by this paper
• Plasma coenzyme Q10 response to oral ingestion of coenzyme Q10 formulations.

  2007cited by this paper
• The Quality Control Assessment of Commercially Available Coenzyme Q10-Containing Dietary and Health Supplements in Japan

  2007cited by this paper
• The uptake and distribution of coenzyme Q10.

  2007cited by this paper
• Coenzyme Q10 Deficiency and Response to Supplementation in Pediatric and Adolescent Migraine

  2007cited by this paper
• Infantile and pediatric quinone deficiency diseases.

  2007cited by this paper
• A pilot clinical trial of the effects of coenzyme Q10 on chronic tinnitus aurium

  2007cited by this paper
• The uptake and distribution of coenzyme Q(10)

  2007cited by this paper
• Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials

  2007cited by this paper
• A mutation in para-hydroxybenzoate-polyprenyl transferase (COQ2) causes primary coenzyme Q10 deficiency.

  2006cited by this paper
• Comparison of the relative bioavailability of different coenzyme Q10 formulations with a novel solubilizate (Solu™ Q10)

  2006cited by this paper
• Formulation of medicines for children.

  2005cited by this paper
• Coenzyme Q10.

  2005cited by this paper
• Efficacy of coenzyme Q10 in migraine prophylaxis: A randomized controlled trial

  2005cited by this paper
• Relative Bioavailability and Antioxidant Potential of Two Coenzyme Q10 Preparations

  2003cited by this paper
• Comparative bioavailability of two novel coenzyme Q10 preparations in humans.

  2003cited by this paper
• Total coenzyme Q10 concentrations in Asian men following multiple oral 50-mg doses administered as coenzyme Q10 sustained release tablets or regular tablets.

  2003influential reference
• Issues in the Formulation of Drugs for Oral Use in Children

  2002cited by this paper
• Bioequivalence of coenzyme Q10 from over-the-counter supplements

  2002cited by this paper
• Biochemical Functions of Coenzyme Q10

  2001cited by this paper
• Similar therapeutic serum levels attained with emulsified and oil-based preparations of coenzyme Q10.

  2001cited by this paper
• Relative bioavailability of coenzyme Q10 formulations in human subjects.

  1998influential reference
• Bioavailability of four oral coenzyme Q10 formulations in healthy volunteers.

  1994cited by this paper
• Improved high-performance liquid chromatographic method for the determination of coenzyme Q10 in plasma.

  1992cited by this paper
• Evidence for the in vivo formation of ascorbic acid 2-O-α-glucoside in guinea pigs and rats

  1991cited by this paper
• Evidence for the in vivo formation of ascorbic acid 2-O-alpha-glucoside in guinea pigs and rats.

  1991cited by this paper

• Comparative review of translational approaches in lipid-based and water-based encapsulation strategies for coenzyme Q10

  2025cites this paper
• Bioavailability and Cellular Compatibility of a Novel Coenzyme Q10 Emulgel as an Alternative Oral Delivery System for Patients with Dysphagia: Preliminary Results from a Randomized Study

  2025influential citation
• North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition 2025 guidelines for management of cyclic vomiting syndrome in children.

  2025cites this paper
• Advances in micro- and nano- delivery systems for increasing the stability, bioavailability and bioactivity of coenzyme Q10

  2025cites this paper
• Coenzyme Q10: Does it benefit neurological diseases?

  2024cites this paper
• Synthesis of Graphene Oxide Shielded Highly Stable Nano Liposomes for Intestinal Delivery of CoQ10

  2024cites this paper
• CoQ10Phytosomes Improve Cellular Ubiquinone Uptake in Skeletal Muscle Cells: An Ex Vivo Study Using CoQ10-Enriched Low-Density Lipoproteins Obtained in a Randomized Crossover Study

  2023cites this paper
• Characterization and bioavailability of a novel Coenzyme Q10 nanoemulsion used as an infant formula supplement.

  2023cites this paper
• Formulation Of Coenzyme Q10 Liquid Foundation With a Variations Virgin Coconut Oil as The Oil Phase

  2022cites this paper
• Modulation of Obesity in Sub-Saharan Africa Using Coenzyme Q10

  2022cites this paper
• Genotoxic risk in humans and acute toxicity in rats of a novel oral high-dose coenzyme Q10 oleogel

  2021cites this paper
• Coenzyme Q10 and the exclusive club of diseases that show a limited response to treatment

  2021cites this paper
• The therapeutic efficacy of water-soluble coenzyme Q10 in an experimental model of tacrolimus-induced diabetes mellitus

  2020cites this paper
• Coenzyme Q10: Clinical Applications in Cardiovascular Diseases

  2020cites this paper
• Bioavailability of coenzyme Q10 loaded in an oleogel formulation for oral therapy: comparison with a commercial-grade solid formulation.

  2020cites this paper
• Bioavailability of coenzyme Q10 supplements depends on carrier lipids and solubilization.

  2019cites this paper
• Chronic kidney disease and coenzyme Q10 supplementation

  2019cites this paper
• High-dose coenzyme Q10-loaded oleogels for oral therapeutic supplementation.

  2019cites this paper
• Coenzyme Q10 in the Treatment of Mitochondrial Disease

  2017cites this paper